Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Milk, Human | 26 | 2025 | 91 | 5.660 |
Why?
|
| Infant, Premature | 27 | 2025 | 119 | 4.960 |
Why?
|
| Breast Feeding | 24 | 2025 | 83 | 4.730 |
Why?
|
| Infant, Very Low Birth Weight | 20 | 2020 | 84 | 4.310 |
Why?
|
| Intensive Care Units, Neonatal | 25 | 2025 | 101 | 4.090 |
Why?
|
| Mothers | 17 | 2025 | 92 | 2.490 |
Why?
|
| Infant, Newborn | 44 | 2025 | 312 | 2.410 |
Why?
|
| Lactation | 13 | 2023 | 33 | 2.340 |
Why?
|
| Child Development | 8 | 2020 | 52 | 1.330 |
Why?
|
| Infant Nutritional Physiological Phenomena | 11 | 2025 | 35 | 1.170 |
Why?
|
| Peer Group | 5 | 2017 | 19 | 1.140 |
Why?
|
| Enterocolitis, Necrotizing | 6 | 2020 | 25 | 1.080 |
Why?
|
| Female | 35 | 2025 | 6974 | 1.040 |
Why?
|
| Breast Milk Expression | 5 | 2017 | 20 | 1.000 |
Why?
|
| Infant, Premature, Diseases | 5 | 2019 | 13 | 0.980 |
Why?
|
| Humans | 46 | 2025 | 12240 | 0.980 |
Why?
|
| Health Care Costs | 4 | 2020 | 32 | 0.850 |
Why?
|
| Infant | 12 | 2025 | 277 | 0.830 |
Why?
|
| Neonatal Nursing | 5 | 2018 | 8 | 0.790 |
Why?
|
| Intensive Care, Neonatal | 5 | 2020 | 16 | 0.770 |
Why?
|
| Mother-Child Relations | 5 | 2017 | 16 | 0.760 |
Why?
|
| Gestational Age | 8 | 2020 | 52 | 0.750 |
Why?
|
| Socioeconomic Factors | 3 | 2020 | 153 | 0.690 |
Why?
|
| Maternal Behavior | 3 | 2017 | 7 | 0.680 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 34 | 0.670 |
Why?
|
| Postnatal Care | 2 | 2013 | 6 | 0.660 |
Why?
|
| Milk Banks | 3 | 2019 | 13 | 0.660 |
Why?
|
| Social Determinants of Health | 1 | 2020 | 17 | 0.650 |
Why?
|
| Social Support | 5 | 2017 | 98 | 0.640 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2019 | 11 | 0.640 |
Why?
|
| Health Promotion | 3 | 2013 | 78 | 0.590 |
Why?
|
| Prospective Studies | 9 | 2019 | 817 | 0.570 |
Why?
|
| Birth Weight | 5 | 2020 | 28 | 0.490 |
Why?
|
| Educational Status | 2 | 2016 | 130 | 0.480 |
Why?
|
| Depression, Postpartum | 2 | 2017 | 9 | 0.480 |
Why?
|
| Child Language | 1 | 2016 | 10 | 0.470 |
Why?
|
| Adult | 15 | 2025 | 3557 | 0.470 |
Why?
|
| Patient Discharge | 5 | 2025 | 77 | 0.460 |
Why?
|
| Puerperal Disorders | 1 | 2015 | 4 | 0.450 |
Why?
|
| Counseling | 3 | 2013 | 20 | 0.450 |
Why?
|
| Cost Savings | 1 | 2015 | 15 | 0.440 |
Why?
|
| Anxiety Disorders | 1 | 2015 | 84 | 0.420 |
Why?
|
| Motor Activity | 1 | 2016 | 175 | 0.420 |
Why?
|
| Stress Disorders, Post-Traumatic | 2 | 2017 | 134 | 0.420 |
Why?
|
| Intestines | 2 | 2013 | 33 | 0.420 |
Why?
|
| Male | 17 | 2025 | 6815 | 0.410 |
Why?
|
| Longitudinal Studies | 6 | 2019 | 651 | 0.390 |
Why?
|
| Infant Care | 4 | 2016 | 13 | 0.380 |
Why?
|
| Infant, Low Birth Weight | 3 | 2017 | 7 | 0.370 |
Why?
|
| Nutritive Value | 2 | 2020 | 10 | 0.350 |
Why?
|
| Premature Birth | 2 | 2023 | 14 | 0.350 |
Why?
|
| Goals | 3 | 2017 | 24 | 0.350 |
Why?
|
| Cognition | 1 | 2016 | 641 | 0.340 |
Why?
|
| Chicago | 4 | 2016 | 453 | 0.330 |
Why?
|
| Weight Gain | 2 | 2007 | 30 | 0.330 |
Why?
|
| Infant, Newborn, Diseases | 2 | 2020 | 9 | 0.330 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2010 | 13 | 0.310 |
Why?
|
| United States | 7 | 2020 | 989 | 0.290 |
Why?
|
| Suction | 1 | 2008 | 8 | 0.280 |
Why?
|
| Anthropometry | 2 | 2007 | 20 | 0.280 |
Why?
|
| Breast | 1 | 2008 | 9 | 0.280 |
Why?
|
| Nurse's Role | 3 | 2007 | 29 | 0.280 |
Why?
|
| Infant Formula | 2 | 2019 | 11 | 0.280 |
Why?
|
| Risk Factors | 4 | 2016 | 1049 | 0.280 |
Why?
|
| Bottle Feeding | 3 | 2016 | 6 | 0.250 |
Why?
|
| Maternal-Child Nursing | 2 | 2004 | 4 | 0.240 |
Why?
|
| Sepsis | 2 | 2019 | 38 | 0.240 |
Why?
|
| Hospitalization | 3 | 2018 | 158 | 0.230 |
Why?
|
| Diet | 2 | 2018 | 104 | 0.230 |
Why?
|
| Parent-Child Relations | 1 | 2004 | 15 | 0.210 |
Why?
|
| Parents | 1 | 2004 | 51 | 0.200 |
Why?
|
| Adolescent | 5 | 2017 | 989 | 0.200 |
Why?
|
| Decision Making | 3 | 2015 | 95 | 0.200 |
Why?
|
| Financing, Government | 1 | 2003 | 3 | 0.190 |
Why?
|
| Research Support as Topic | 1 | 2003 | 9 | 0.190 |
Why?
|
| Health Policy | 1 | 2003 | 20 | 0.190 |
Why?
|
| Retrospective Studies | 4 | 2025 | 1467 | 0.180 |
Why?
|
| Reproducibility of Results | 2 | 2002 | 324 | 0.180 |
Why?
|
| Nursing Evaluation Research | 3 | 2015 | 13 | 0.170 |
Why?
|
| Oxidative Stress | 2 | 2018 | 53 | 0.170 |
Why?
|
| Child | 2 | 2020 | 614 | 0.170 |
Why?
|
| Health Expenditures | 1 | 2020 | 7 | 0.160 |
Why?
|
| Aftercare | 2 | 2018 | 16 | 0.160 |
Why?
|
| Nutritional Status | 1 | 2020 | 33 | 0.160 |
Why?
|
| Neonatology | 1 | 2020 | 3 | 0.160 |
Why?
|
| Perception | 1 | 2020 | 42 | 0.160 |
Why?
|
| Milk Ejection | 2 | 2011 | 2 | 0.160 |
Why?
|
| Intestinal Mucosa | 2 | 2018 | 81 | 0.160 |
Why?
|
| Inflammation | 2 | 2018 | 124 | 0.150 |
Why?
|
| Age Factors | 1 | 2020 | 350 | 0.150 |
Why?
|
| Child, Preschool | 1 | 2020 | 320 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2019 | 827 | 0.150 |
Why?
|
| Return to Work | 2 | 2016 | 18 | 0.150 |
Why?
|
| Program Evaluation | 2 | 2013 | 55 | 0.150 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 12 | 0.150 |
Why?
|
| Biomedical Research | 2 | 2016 | 27 | 0.140 |
Why?
|
| Cell Death | 1 | 2018 | 22 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 40 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 10 | 0.130 |
Why?
|
| Pregnancy in Adolescence | 1 | 2017 | 5 | 0.130 |
Why?
|
| Anxiety | 1 | 2017 | 73 | 0.130 |
Why?
|
| Nurse-Patient Relations | 2 | 2015 | 17 | 0.120 |
Why?
|
| Illinois | 1 | 2016 | 110 | 0.120 |
Why?
|
| Tissue Donors | 1 | 2016 | 42 | 0.120 |
Why?
|
| Weaning | 1 | 2016 | 5 | 0.120 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 29 | 0.120 |
Why?
|
| Gastrointestinal Tract | 1 | 2016 | 20 | 0.120 |
Why?
|
| Bacteria | 1 | 2016 | 34 | 0.120 |
Why?
|
| Informed Consent | 1 | 2015 | 13 | 0.120 |
Why?
|
| Linear Models | 1 | 2016 | 115 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 141 | 0.110 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 2015 | 3 | 0.110 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2015 | 13 | 0.110 |
Why?
|
| Life Change Events | 1 | 2015 | 21 | 0.110 |
Why?
|
| Incubators, Infant | 2 | 1995 | 2 | 0.110 |
Why?
|
| Young Adult | 2 | 2016 | 863 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2016 | 74 | 0.110 |
Why?
|
| Pregnancy | 3 | 2017 | 193 | 0.110 |
Why?
|
| Clinical Nursing Research | 1 | 1994 | 3 | 0.100 |
Why?
|
| Beds | 1 | 1994 | 3 | 0.100 |
Why?
|
| Animals | 3 | 2015 | 2092 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2019 | 1478 | 0.100 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 546 | 0.100 |
Why?
|
| Focus Groups | 1 | 1994 | 50 | 0.100 |
Why?
|
| Swine | 1 | 2013 | 43 | 0.100 |
Why?
|
| Models, Animal | 1 | 2013 | 74 | 0.100 |
Why?
|
| Microbiota | 1 | 2013 | 35 | 0.100 |
Why?
|
| Program Development | 1 | 2013 | 26 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 116 | 0.090 |
Why?
|
| Morphogenesis | 1 | 2012 | 4 | 0.090 |
Why?
|
| Mammary Glands, Human | 1 | 2012 | 5 | 0.090 |
Why?
|
| Quadruplets | 1 | 1992 | 1 | 0.090 |
Why?
|
| Patient Education as Topic | 2 | 2003 | 64 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2017 | 79 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 72 | 0.090 |
Why?
|
| Time Factors | 2 | 2011 | 695 | 0.090 |
Why?
|
| Reference Values | 1 | 2011 | 103 | 0.080 |
Why?
|
| Energy Intake | 2 | 2018 | 46 | 0.080 |
Why?
|
| Evidence-Based Medicine | 2 | 2020 | 78 | 0.080 |
Why?
|
| Colostrum | 1 | 2010 | 2 | 0.080 |
Why?
|
| Personal Satisfaction | 1 | 2008 | 11 | 0.070 |
Why?
|
| Models, Biological | 1 | 2009 | 191 | 0.070 |
Why?
|
| Midwifery | 1 | 2007 | 1 | 0.070 |
Why?
|
| Nursing Diagnosis | 1 | 2007 | 1 | 0.070 |
Why?
|
| Qualitative Research | 2 | 2017 | 56 | 0.060 |
Why?
|
| Object Attachment | 1 | 2004 | 1 | 0.050 |
Why?
|
| Nursing Methodology Research | 1 | 2004 | 18 | 0.050 |
Why?
|
| Models, Nursing | 1 | 2004 | 6 | 0.050 |
Why?
|
| Nigeria | 1 | 2003 | 1 | 0.050 |
Why?
|
| Health Planning Support | 1 | 2003 | 1 | 0.050 |
Why?
|
| Healthy People Programs | 1 | 2003 | 2 | 0.050 |
Why?
|
| Databases, Bibliographic | 1 | 2003 | 2 | 0.050 |
Why?
|
| Politics | 1 | 2003 | 6 | 0.050 |
Why?
|
| Conflict of Interest | 1 | 2003 | 3 | 0.050 |
Why?
|
| Policy Making | 1 | 2003 | 6 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2003 | 12 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2003 | 113 | 0.050 |
Why?
|
| Lipids | 1 | 2002 | 28 | 0.050 |
Why?
|
| Nurseries, Hospital | 1 | 2001 | 2 | 0.040 |
Why?
|
| Postpartum Period | 1 | 2020 | 11 | 0.040 |
Why?
|
| Risk | 1 | 2020 | 97 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 43 | 0.040 |
Why?
|
| Health Status Disparities | 1 | 2020 | 30 | 0.040 |
Why?
|
| Nutritional Support | 1 | 2018 | 10 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 22 | 0.030 |
Why?
|
| Food, Fortified | 1 | 2018 | 6 | 0.030 |
Why?
|
| F2-Isoprostanes | 1 | 2018 | 6 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 41 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 95 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 18 | 0.030 |
Why?
|
| Biomarkers | 1 | 2018 | 294 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 726 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 196 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 22 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 23 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2016 | 28 | 0.030 |
Why?
|
| Phylogeny | 1 | 2016 | 35 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 40 | 0.030 |
Why?
|
| Interviews as Topic | 1 | 2015 | 66 | 0.030 |
Why?
|
| Depression | 1 | 2017 | 229 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2015 | 3 | 0.030 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2015 | 6 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 8 | 0.030 |
Why?
|
| Body Weight | 1 | 1995 | 72 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 90 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2015 | 53 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 150 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 39 | 0.030 |
Why?
|
| Transportation of Patients | 1 | 1994 | 4 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 1994 | 13 | 0.030 |
Why?
|
| Nurse Clinicians | 1 | 1994 | 3 | 0.030 |
Why?
|
| Research Personnel | 1 | 1994 | 12 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 1994 | 29 | 0.030 |
Why?
|
| Group Processes | 1 | 1994 | 9 | 0.030 |
Why?
|
| Mice | 1 | 2015 | 760 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 2012 | 1 | 0.020 |
Why?
|
| Milk | 1 | 2012 | 5 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 29 | 0.020 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 6 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 28 | 0.020 |
Why?
|
| Cesarean Section | 1 | 1992 | 20 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 218 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2004 | 8 | 0.010 |
Why?
|
| Urban Population | 1 | 2004 | 78 | 0.010 |
Why?
|
| Electronics | 1 | 1995 | 4 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1995 | 46 | 0.010 |
Why?
|
| Observer Variation | 1 | 1995 | 47 | 0.010 |
Why?
|
| Critical Illness | 1 | 1995 | 53 | 0.010 |
Why?
|